JPS59501612A - 血液成分貯蔵容器 - Google Patents
血液成分貯蔵容器Info
- Publication number
- JPS59501612A JPS59501612A JP58502663A JP50266383A JPS59501612A JP S59501612 A JPS59501612 A JP S59501612A JP 58502663 A JP58502663 A JP 58502663A JP 50266383 A JP50266383 A JP 50266383A JP S59501612 A JPS59501612 A JP S59501612A
- Authority
- JP
- Japan
- Prior art keywords
- parts
- container
- weight
- paragraph
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003860 storage Methods 0.000 title claims description 40
- 239000012503 blood component Substances 0.000 title claims description 26
- 239000000203 mixture Substances 0.000 claims description 87
- 210000004369 blood Anatomy 0.000 claims description 64
- 239000008280 blood Substances 0.000 claims description 64
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 57
- 239000004800 polyvinyl chloride Substances 0.000 claims description 57
- 239000004014 plasticizer Substances 0.000 claims description 50
- 239000011347 resin Substances 0.000 claims description 49
- 229920005989 resin Polymers 0.000 claims description 49
- 238000009472 formulation Methods 0.000 claims description 32
- 210000001772 blood platelet Anatomy 0.000 claims description 27
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 21
- 235000013539 calcium stearate Nutrition 0.000 claims description 21
- 239000008116 calcium stearate Substances 0.000 claims description 21
- 239000003634 thrombocyte concentrate Substances 0.000 claims description 20
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims description 20
- 230000006641 stabilisation Effects 0.000 claims description 19
- 238000011105 stabilization Methods 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- 239000002981 blocking agent Substances 0.000 claims description 14
- 239000000306 component Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 230000000087 stabilizing effect Effects 0.000 claims description 14
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 13
- 239000011701 zinc Substances 0.000 claims description 13
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 11
- 229920003023 plastic Polymers 0.000 claims description 11
- 239000004033 plastic Substances 0.000 claims description 11
- 235000021355 Stearic acid Nutrition 0.000 claims description 10
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 10
- 239000008117 stearic acid Substances 0.000 claims description 10
- 229910052725 zinc Inorganic materials 0.000 claims description 10
- KRADHMIOFJQKEZ-UHFFFAOYSA-N Tri-2-ethylhexyl trimellitate Chemical compound CCCCC(CC)COC(=O)C1=CC=C(C(=O)OCC(CC)CCCC)C(C(=O)OCC(CC)CCCC)=C1 KRADHMIOFJQKEZ-UHFFFAOYSA-N 0.000 claims description 9
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 7
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 210000003743 erythrocyte Anatomy 0.000 claims description 6
- -1 2-ethylhexyl Chemical group 0.000 claims description 5
- 239000006260 foam Substances 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 159000000007 calcium salts Chemical class 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 4
- 230000035899 viability Effects 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 125000005591 trimellitate group Chemical group 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 229920002457 flexible plastic Polymers 0.000 claims 2
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims 1
- 239000000853 adhesive Substances 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 230000002439 hemostatic effect Effects 0.000 claims 1
- 230000002706 hydrostatic effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 239000012760 heat stabilizer Substances 0.000 description 9
- 239000011575 calcium Substances 0.000 description 8
- 210000002381 plasma Anatomy 0.000 description 8
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000002386 leaching Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 101100243025 Arabidopsis thaliana PCO2 gene Proteins 0.000 description 5
- 239000003146 anticoagulant agent Substances 0.000 description 5
- 229940127219 anticoagulant drug Drugs 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- 239000008158 vegetable oil Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000012633 leachable Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000006161 blood agar Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000003490 calendering Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HBGGXOJOCNVPFY-UHFFFAOYSA-N diisononyl phthalate Chemical compound CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C HBGGXOJOCNVPFY-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002194 fatty esters Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- NCQKSUNJAAZVJW-UKTHLTGXSA-N (2e)-2-(2-phenylethylhydrazinylidene)propanoic acid Chemical compound OC(=O)C(/C)=N/NCCC1=CC=CC=C1 NCQKSUNJAAZVJW-UKTHLTGXSA-N 0.000 description 1
- XOHUEYCVLUUEJJ-UHFFFAOYSA-N 2,3-Bisphosphoglyceric acid Chemical compound OP(=O)(O)OC(C(=O)O)COP(O)(O)=O XOHUEYCVLUUEJJ-UHFFFAOYSA-N 0.000 description 1
- YEVQZPWSVWZAOB-UHFFFAOYSA-N 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(I)C(CBr)=C1 YEVQZPWSVWZAOB-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 101100243026 Arabidopsis thaliana PCO3 gene Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 241001553014 Myrsine salicina Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 229920001944 Plastisol Polymers 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 241000212342 Sium Species 0.000 description 1
- 239000004930 VINNOL Substances 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000012953 feeding on blood of other organism Effects 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000007567 mass-production technique Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- GIPDEPRRXIBGNF-KTKRTIGZSA-N oxolan-2-ylmethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC1CCCO1 GIPDEPRRXIBGNF-KTKRTIGZSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000004999 plastisol Substances 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940072958 tetrahydrofurfuryl oleate Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 239000001973 thioglycolate broth Substances 0.000 description 1
- 239000007143 thioglycolate medium Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- GSURLQOINUQIIH-UHFFFAOYSA-N triheptyl phosphate Chemical compound CCCCCCCOP(=O)(OCCCCCCC)OCCCCCCC GSURLQOINUQIIH-UHFFFAOYSA-N 0.000 description 1
- MXHBQKVKHGQWRB-UHFFFAOYSA-N trihexyl benzene-1,2,4-tricarboxylate Chemical compound CCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCC)C(C(=O)OCCCCCC)=C1 MXHBQKVKHGQWRB-UHFFFAOYSA-N 0.000 description 1
- SFENPMLASUEABX-UHFFFAOYSA-N trihexyl phosphate Chemical compound CCCCCCOP(=O)(OCCCCCC)OCCCCCC SFENPMLASUEABX-UHFFFAOYSA-N 0.000 description 1
- YPDXSCXISVYHOB-UHFFFAOYSA-N tris(7-methyloctyl) benzene-1,2,4-tricarboxylate Chemical compound CC(C)CCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCCC(C)C)C(C(=O)OCCCCCCC(C)C)=C1 YPDXSCXISVYHOB-UHFFFAOYSA-N 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- 229910000165 zinc phosphate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/143—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/141—Plasticizers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/10—Esters; Ether-esters
- C08K5/12—Esters; Ether-esters of cyclic polycarboxylic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/24—Medical-surgical bags
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Liquid Crystal (AREA)
- External Artificial Organs (AREA)
- Materials For Medical Uses (AREA)
- Liquid Crystal Display Device Control (AREA)
- Transforming Electric Information Into Light Information (AREA)
- Control Of Indicators Other Than Cathode Ray Tubes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US424679 | 1982-09-27 | ||
| US06/424,679 US4505708A (en) | 1982-09-27 | 1982-09-27 | Blood component storage container and method utilizing a polyvinyl chloride plastic formulation free or essentially free of leachable materials |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59501612A true JPS59501612A (ja) | 1984-09-13 |
| JPH0416183B2 JPH0416183B2 (enExample) | 1992-03-23 |
Family
ID=23683486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58502663A Granted JPS59501612A (ja) | 1982-09-27 | 1983-07-21 | 血液成分貯蔵容器 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4505708A (enExample) |
| EP (1) | EP0120873B1 (enExample) |
| JP (1) | JPS59501612A (enExample) |
| AU (1) | AU573181B2 (enExample) |
| CA (1) | CA1237075A (enExample) |
| DE (1) | DE3381486D1 (enExample) |
| WO (1) | WO1984001286A1 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0292358A (ja) * | 1988-09-28 | 1990-04-03 | Terumo Corp | 血小板保存用容器および血小板の保存方法 |
| JPH02177961A (ja) * | 1988-12-28 | 1990-07-11 | Kawasumi Lab Inc | 医療用具 |
| JPH0614990A (ja) * | 1991-04-08 | 1994-01-25 | Kawasumi Lab Inc | 医療用具 |
| JP2016147954A (ja) * | 2015-02-12 | 2016-08-18 | リケンテクノス株式会社 | 医療用塩化ビニル系樹脂組成物 |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD284035S (en) | 1983-05-23 | 1986-05-27 | Union Carbide Corporation | Chemical container |
| AU569544B2 (en) * | 1983-10-14 | 1988-02-04 | Pall Corporation | Citrate-ester plasticized pvc blood containers |
| US5167657A (en) * | 1988-11-14 | 1992-12-01 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US5100401A (en) * | 1988-11-14 | 1992-03-31 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US5026347A (en) * | 1988-11-14 | 1991-06-25 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US4943287A (en) * | 1989-07-17 | 1990-07-24 | Miles Inc. | Red blood cell storage system |
| US5250044A (en) * | 1990-02-06 | 1993-10-05 | Du Pont Merck Pharmaceutical Company | Blood cryopreservation container |
| US5460625A (en) * | 1990-07-31 | 1995-10-24 | Baxter International Inc. | Cryogenic resistant coextruded tubing |
| US5683768A (en) * | 1994-12-21 | 1997-11-04 | Baxter International Inc. | Plastic formulations for platelet storage containers and the like |
| US6984526B2 (en) * | 1995-02-08 | 2006-01-10 | University Of South Florida | Spectrophotometric method for determining the viability of a sample containing platelets |
| US6146124A (en) | 1996-06-25 | 2000-11-14 | Thermogenesis Corp. | Freezing and thawing bag, mold, apparatus and method |
| US6808675B1 (en) | 1996-06-25 | 2004-10-26 | Thermogenesis Corp. | Freezing and thawing bag, mold, apparatus and method |
| US6213334B1 (en) | 1996-09-05 | 2001-04-10 | Baxter International Inc | Flexible, three-dimensional containers and methods for making them |
| US6361642B1 (en) | 1997-12-02 | 2002-03-26 | Baxter International Inc. | Heat and pressure-formed flexible containers |
| US6059968A (en) * | 1998-01-20 | 2000-05-09 | Baxter International Inc. | Systems for processing and storing placenta/umbilical cord blood |
| EP0995419B1 (en) * | 1998-10-21 | 2005-12-21 | Nipro Corporation | Method for producing a plastic vessel containing an albumin preparation |
| US20100087546A1 (en) * | 2005-04-20 | 2010-04-08 | Biogenic Innovations, Llc | Use of dimethyl sulfone (msm) to reduce homocysteine levels |
| WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
| CA2622204C (en) | 2005-09-12 | 2016-10-11 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same |
| WO2007033082A2 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
| US8480797B2 (en) * | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
| US8449520B2 (en) * | 2007-03-19 | 2013-05-28 | HemCon Medical Technologies Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
| US7776022B2 (en) * | 2007-03-19 | 2010-08-17 | Hemcon Medical Technologies | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
| BRPI0921494A2 (pt) * | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
| MX353712B (es) | 2009-10-30 | 2018-01-24 | Abela Pharmaceuticals Inc | Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis. |
| US9993389B2 (en) | 2011-09-19 | 2018-06-12 | Fenwal, Inc. | Red blood cell products and the storage of red blood cells in containers free of phthalate plasticizer |
| US9579253B2 (en) * | 2012-11-08 | 2017-02-28 | Grifols Worldwide Operations Limited | RFID tag and blood container/system with integrated RFID tag |
| KR102554521B1 (ko) | 2014-02-20 | 2023-07-11 | 프레제니우스 카비 도이치란트 게엠베하 | 적혈구 제품, 혈장 및 혈소판의 보관을 위한 비-ｄｅｈｐ 가소제를 갖는 의료용 컨테이너 및 시스템 구성요소 |
| CN113930028B (zh) * | 2021-10-20 | 2023-02-24 | 台湾塑胶工业股份有限公司 | 抗沾粘材料、含其的接触血液的医疗器材及其制造方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS535337A (en) * | 1976-07-01 | 1978-01-18 | Bosch Gmbh Robert | Centrifugal rotation controller for injection type internal combustion engine |
| EP0054221A1 (en) * | 1980-12-15 | 1982-06-23 | Miles Inc. | Multiple blood bag system made of plastic substantially free of blood extractible plasticizers |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2275957A (en) * | 1938-02-11 | 1942-03-10 | Carbide & Carbon Chem Corp | Process for coating and laminating materials |
| GB584434A (en) * | 1944-01-24 | 1947-01-15 | Wingfoot Corp | Stabilization of vinyl resins |
| US2868745A (en) * | 1957-01-16 | 1959-01-13 | Harshaw Chem Corp | Vinyl chloride resin stabilized with three component stabilizer |
| BE563999A (enExample) * | 1957-01-18 | |||
| GB1460221A (en) * | 1974-01-21 | 1976-12-31 | British Petroleum Co | Stabilised vinyl chloride polymers |
| US3929700A (en) * | 1974-04-29 | 1975-12-30 | Hooker Chemicals Plastics Corp | Polyvinyl chloride composition |
| JPS5232900B2 (enExample) * | 1974-10-28 | 1977-08-24 | ||
| US4072790A (en) * | 1974-12-17 | 1978-02-07 | The Goodyear Tire & Rubber Company | Extrudable compounded polyvinyl chloride |
| DE2642509A1 (de) * | 1976-09-22 | 1978-03-23 | Neynaber Chemie Gmbh | Stabilisatorkombination fuer formmassen auf basis von polyvinylchlorid |
| US4346710A (en) * | 1978-06-16 | 1982-08-31 | Pennwalt Corporation | Article for storage and transport of biogenic fluids |
| JPS5560459A (en) * | 1978-10-26 | 1980-05-07 | Baxter Travenol Lab | Polymer that can coexist with blood and medical appliance manufactured from said polymer |
| GB2035093B (en) * | 1978-10-26 | 1983-01-12 | Baxter Travenol Lab | Medical articles made of blood compatible polymers |
| US4222379A (en) * | 1978-10-26 | 1980-09-16 | Baxter Travenol Laboratories, Inc. | Multiple blood bag having plasticizer-free portions and a high blood component survival rate |
| EP0011419A1 (en) * | 1978-11-09 | 1980-05-28 | TATE & LYLE PUBLIC LIMITED COMPANY | P.V.C. compositions for extrusion moulding |
| US4252705A (en) * | 1978-12-26 | 1981-02-24 | Argus Chemical Corporation | Resistance of polyvinyl chloride resins to discoloration during drying with N,N'-diphenyl urea |
| DE2914463A1 (de) * | 1979-04-10 | 1980-10-23 | Hoechst Ag | Medizinische geraete fuer parenterale fluessigkeiten |
| US4269743A (en) * | 1979-06-04 | 1981-05-26 | Dart Industries Inc. | Low toxicity vinyl halide stabilizer compositions |
| US4269744A (en) * | 1979-06-04 | 1981-05-26 | Dart Industries Inc. | Vinyl halide stabilizer compositions |
| US4280497A (en) * | 1979-10-09 | 1981-07-28 | Cutter Laboratories, Inc. | Container for platelet storage |
| AU1947083A (en) * | 1982-09-27 | 1984-04-24 | Baxter Travenol Laboratories Inc. | Method and container for storing platelets |
-
1982
- 1982-09-27 US US06/424,679 patent/US4505708A/en not_active Expired - Lifetime
-
1983
- 1983-07-21 DE DE8383902616T patent/DE3381486D1/de not_active Expired - Lifetime
- 1983-07-21 WO PCT/US1983/001133 patent/WO1984001286A1/en not_active Ceased
- 1983-07-21 JP JP58502663A patent/JPS59501612A/ja active Granted
- 1983-07-21 EP EP83902616A patent/EP0120873B1/en not_active Expired - Lifetime
- 1983-07-21 AU AU18807/83A patent/AU573181B2/en not_active Ceased
- 1983-08-19 CA CA000434933A patent/CA1237075A/en not_active Expired
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS535337A (en) * | 1976-07-01 | 1978-01-18 | Bosch Gmbh Robert | Centrifugal rotation controller for injection type internal combustion engine |
| EP0054221A1 (en) * | 1980-12-15 | 1982-06-23 | Miles Inc. | Multiple blood bag system made of plastic substantially free of blood extractible plasticizers |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0292358A (ja) * | 1988-09-28 | 1990-04-03 | Terumo Corp | 血小板保存用容器および血小板の保存方法 |
| JPH02177961A (ja) * | 1988-12-28 | 1990-07-11 | Kawasumi Lab Inc | 医療用具 |
| JPH0614990A (ja) * | 1991-04-08 | 1994-01-25 | Kawasumi Lab Inc | 医療用具 |
| JP2016147954A (ja) * | 2015-02-12 | 2016-08-18 | リケンテクノス株式会社 | 医療用塩化ビニル系樹脂組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1880783A (en) | 1984-04-24 |
| CA1237075A (en) | 1988-05-24 |
| JPH0416183B2 (enExample) | 1992-03-23 |
| AU573181B2 (en) | 1988-06-02 |
| EP0120873A4 (en) | 1986-11-26 |
| EP0120873A1 (en) | 1984-10-10 |
| EP0120873B1 (en) | 1990-04-25 |
| DE3381486D1 (de) | 1990-05-31 |
| US4505708A (en) | 1985-03-19 |
| WO1984001286A1 (en) | 1984-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS59501612A (ja) | 血液成分貯蔵容器 | |
| US4670013A (en) | Container for blood and blood components | |
| AU571616B2 (en) | Medium for storing blood platelets | |
| Simmchen et al. | Progress in the removal of di-[2-ethylhexyl]-phthalate as plasticizer in blood bags | |
| AU589299B2 (en) | Glucose free media for storing blood platelets | |
| EP0313808B1 (en) | Synthetic, plasma-free, transfusible storage medium for red blood cells | |
| US4992363A (en) | Method for preparing glucose free media for storing blood platelets | |
| EP0537863B1 (en) | Use of a triglyceride compound as a hemolysis depressant | |
| JPH0136384B2 (enExample) | ||
| JPH0131904B2 (enExample) | ||
| SE461190B (sv) | Foerfarande foer foervaring av blod samt behaallare innehaallande antihemolytiskt medel | |
| US5248531A (en) | Hemolysis depressant and plasticizer | |
| EP3744775A1 (en) | Blood storage containers made of polyvinyl chloride and mixed plasticizers | |
| EP0334956A1 (en) | Hemolysis inhibitor and medical resin composition, medical implement, and blood-preserving fluid containing the same | |
| CA1285094C (en) | Pvc containers for blood and blood components | |
| Koerner | Platelet function of room temperature platelet concentrates stored in a new plastic material with high gas permeability | |
| Chawla et al. | Leaching of plasticizers from and surface characterization of PVC blood platelet bags | |
| EP0331729A1 (en) | Medical implements | |
| CA1306698C (en) | Hemolysis depressant, and medical resin composition, medical implement and blood preserving liquid using the hemolysis depressant | |
| Davey et al. | Characteristics of white cell‐reduced red cells stored in tri‐(2‐ethylhexyl) trimellitate plastic | |
| JP2024500767A (ja) | 保存された赤血球の溶血を抑制するための使い捨て流体回路および容器 | |
| JPH0292358A (ja) | 血小板保存用容器および血小板の保存方法 | |
| JPS62281946A (ja) | 血液バツグセツト |